FDA Inspection
Huntington Reproductive Center Medical GroupHuntington Reproductive Center Medical Group – FDA Inspection, Mar 28, 2023
Record Details
This FDA Inspection record concerns Huntington Reproductive Center Medical Group, with an inspection on March 28, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 28, 2023
- Product Type
- Biologics
View Company Profile
ID · cebf25f4-6a5e-4f06-9f66-75683b4c873e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1201073
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.50(a)Determination based on screening and testing
- 21 CFR 1271.55(c)Name and personal info on accompanying records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Huntington Reproductive Center Medical Group
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 29, 2024 | VAI | Los Angeles District Office | Human Cellular, Tissue, and Gene Therapies |
| March 23, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 9, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Huntington Reproductive Center Medical Group
- FDA Inspection 1253031 - 2024-10-29
- FDA Inspection 1056321 - 2018-03-23
- FDA Inspection 941285 - 2015-09-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.